4//SEC Filing
CASI Pharmaceuticals, Inc. 4
Accession 0001144204-14-068948
CIK 0000895051operating
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 5:14 PM ET
Size
5.5 KB
Accession
0001144204-14-068948
Insider Transaction Report
Form 4
Ren Ken Keyong
Chief Executive Officer
Transactions
- Award
Stock Options(Right to Buy)
2014-04-03+100,000→ 100,000 totalExercise: $1.84Exp: 2024-04-03→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The stock options vested as a result of the reported license transaction with Spectrum Pharmaceuticals, Inc. on September 17, 2014.
Documents
Issuer
CASI Pharmaceuticals, Inc.
CIK 0000895051
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000895051
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 5:14 PM ET
- Size
- 5.5 KB